LeMaitre Vascular, Inc. Acquires InaVein

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., Aug. 28, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it acquired the assets of InaVein, LLC for $2.5mm, or 1.1X InaVein’s 2012 sales, and potential earn-out payments in 2014 and 2015 based on the performance of the acquired business and regulatory approval in China. InaVein owned and marketed the TRIVEX® System, a business that carried a 60-70% gross margin.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC